|
|
||||||||
J Thorac Cardiovasc Surg 2009;138:687-693
© 2009 The American Association for Thoracic Surgery
Perioperative Management |
a Global Development, Novo Nordisk A/S, Bagsværd, Denmark
b Klinik für Herzchirurgie, Herzzentrum Augsburg, Augsburg, Germany
c Pharmametrics GmbH, Institute for Health Economics & Epidemiology, Freiburg, Germany
d Department of Anaesthesiology and Intensive Care Medicine, Charité-University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
Received for publication March 17, 2008; revisions received September 12, 2008; accepted for publication February 2, 2009. * Address for reprints: Michael C. Christensen, MSc, MPA, DrPH, Global Development, Novo Nordisk A/S, Krogshoejvej 55, 2880 Bagsvaerd, Denmark. (Email: mcrc{at}novonordisk.com).
Background: Excessive postoperative hemorrhage in cardiac surgery is a serious clinical complication placing substantial demands on hospital resources. This study quantifies the exact impact of postoperative hemorrhage on hospital costs in Germany.
Methods: We retrospectively analyzed data collected prospectively in the Quality Assurance Database at the Heart Center of the Klinikum Augsburg, Germany. All relevant perioperative data for resources consumption were analyzed and compared in patients with and without excessive postoperative hemorrhage in cardiac surgery. Multivariate regression analysis identified the incremental costs of postoperative hemorrhage while adjusting for potential confounding.
Results: A total of 1118 patients had cardiac surgery between January and December 2006. Six percent were identified with excessive postoperative hemorrhage. The risk of experiencing a postoperative complication (including death) (P < .0001), returning to operating room for reexploration (P < .0001), staying in intensive care unit for longer than 72 hours (P < .0001), receiving ventilation for longer than 24 hours (P < .0001), and receiving any kind of postoperative blood transfusion (P < .0001) was significantly higher in patients with excessive postoperative hemorrhage. Twenty-two percent of patients with excessive postoperative hemorrhage died compared with 6% of the patients without excessive postoperative hemorrhage (P < .0001). When adjusting for potential confounding factors, the incremental costs of excessive postoperative hemorrhage was \#8364;6251 (95% confidence interval, 4594–7909).
Conclusions: The average hospital costs related to excessive postoperative hemorrhage in cardiac surgery in Germany are substantial and associated with a significant risk of postoperative complications and death. Clinical interventions that can effectively prevent or address excessive postoperative hemorrhage in cardiac surgery are likely to have substantial cost-effectiveness potential.
Related Article
J. Thorac. Cardiovasc. Surg. 2010 139: 1667.
This article has been cited by other articles:
![]() |
U. Alstrom, L.- A. Levin, E. Stahle, R. Svedjeholm, and O. Friberg Cost analysis of re-exploration for bleeding after coronary artery bypass graft surgery Br. J. Anaesth., February 1, 2012; 108(2): 216 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Chapman, A. L. Blount, A. T. Davis, and R. L. Hooker Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery Eur J Cardiothorac Surg, December 1, 2011; 40(6): 1314 - 1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sniecinski and J. H. Levy Bleeding and management of coagulopathy J. Thorac. Cardiovasc. Surg., September 1, 2011; 142(3): 662 - 667. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. A. Ferraris, D. L. Davenport, S. P. Saha, A. Bernard, P. C. Austin, and J. B. Zwischenberger Intraoperative Transfusion of Small Amounts of Blood Heralds Worse Postoperative Outcome in Patients Having Noncardiac Thoracic Operations Ann. Thorac. Surg., June 1, 2011; 91(6): 1674 - 1680. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vivacqua, C. G. Koch, A. M. Yousuf, E. R. Nowicki, P. L. Houghtaling, E. H. Blackstone, and J. F. Sabik III Morbidity of Bleeding After Cardiac Surgery: Is It Blood Transfusion, Reoperation for Bleeding, or Both? Ann. Thorac. Surg., June 1, 2011; 91(6): 1780 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Uber, J. M. Toole, M. R. Stroud, J. S. Haney, J. Lazarchick, F. A. Crawford Jr., and J. S. Ikonomidis Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: Clinical and economic outcomes J. Thorac. Cardiovasc. Surg., June 1, 2011; 141(6): 1469 - 1477.e2. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Hessel II and J. H. Levy Guidelines for Perioperative Blood Transfusion and Conservation in Cardiac Surgery: Lessons and Challenges Anesth. Analg., December 1, 2010; 111(6): 1555 - 1559. [Full Text] [PDF] |
||||
![]() |
D. S. Likosky, D. C. FitzGerald, R. C. Groom, D. K. Jones, R. A. Baker, K. G. Shann, C. D. Mazer, B. D. Spiess, and S. C. Body Special Article: Effect of the Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon Clinical Practices Anesth. Analg., August 1, 2010; 111(2): 316 - 323. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |